Literature DB >> 6352806

Biochemical and physicochemical characterization of mouse B cell growth factor: a lymphokine distinct from interleukin 2.

J J Farrar, M Howard, J Fuller-Farrar, W E Paul.   

Abstract

A subline of the C57BL/6 mouse EL-4 thymoma produces upon stimulation with phorbol myristate acetate (PMA) a B cell growth factor (BCGF) that co-stimulates anti-IgM-stimulated splenic B cells. The BCGF present in the EL-4 thymoma culture supernatants is shown to be distinct from IL 2 by a variety of chromatographic criteria. Untreated BCGF exhibits a heterogeneity of isoelectric points (pH 6.4 to 6.6, 7.4 to 7.6, 8.5 to 8.7) all of which are more alkaline than that of IL 2 (pl 3.5 to 4.8). Neuraminidase-treated BCGF exhibits a single major pl of 9.3 that is also distinct from similarly treated IL 2. Moreover, IL 2 and BCGF exhibit distinct monomeric m.w. by SDS gel electrophoresis under nonreducing conditions (IL 2 is 21,000; BCGF is 11,000 and 15,000). The biologic activity of IL 2 is sensitive to trypsin inactivation as is BCGF activity. Thus, BCGF and IL 2 appear to be biologically and biochemically distinct glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352806

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter.

Authors:  J L Evans; T L Moore; W M Kuehl; T Bender; J P Ting
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Identification of a unique B-cell-stimulating factor produced by a cloned dendritic cell.

Authors:  C Clayberger; R H DeKruyff; R Fay; H Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  Ig RNA expression in normal B cells stimulated with anti-IgM antibody and T cell-derived growth and differentiation factors.

Authors:  K Nakanishi; D I Cohen; M Blackman; E Nielsen; J Ohara; T Hamaoka; M E Koshland; W E Paul
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

4.  Interleukin-2 effects on human B cells activated in vivo.

Authors:  T Miyawaki; T Suzuki; J L Butler; M D Cooper
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

5.  Human B lymphoma cell line producing B cell growth factor.

Authors:  J L Ambrus; A S Fauci
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells.

Authors:  James W Austin; Peiyuan Lu; Parimal Majumder; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

7.  Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis.

Authors:  K Nakanishi; T R Malek; K A Smith; T Hamaoka; E M Shevach; W E Paul
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

8.  Leukaemia x fibroblast hybrid cells augment the antibody response to sheep red blood cells in inbred mice.

Authors:  E P Cohen; K Hagen
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

9.  Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-I.

Authors:  M Howard; L Matis; T R Malek; E Shevach; W Kell; D Cohen; K Nakanishi; W E Paul
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

10.  Stimulation of lymphoid cell proliferation by Mycoplasma orale, a common cell culture contaminant.

Authors:  Y Mizushima; J Quintans; E P Cohen
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.